Validity and reliability of the Simpson-Angus Scale (SAS) in drug induced Parkinsonism in the elderly

International Journal of Geriatric Psychiatry

Volumn 24, Issue 2, 2009, Pages 183-189

  Knol, Wilma ^a,b,c   Keijsers, Carolina J P W ^a   Jansen, Paul A F ^a   Belitser, Svetlana V ^c   Schobben, Alfred F A M ^a,c   Egberts, Antoine C G ^a,c   van Marum, Rob J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Tergooiziekenhuizen ^*  (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Antipsychotic drugs; Parkinsonism; Reliability; Simpson Angus Scale; Validity

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AGED; ARTICLE; CLINICAL ARTICLE; CONCURRENT VALIDITY; DRUG INDUCED PARKINSONISM; ELDERLY CARE; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; MALE; NEUROLOGIC EXAMINATION; PARKINSONISM; PSYCHOSIS; RATING SCALE; SALIVATION; SCHEDULE FOR ASSESSMENT OF DRUG INDUCED MOVEMENT DISORDERS; SIMPSON ANGUS SCALE; VALIDITY;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PARKINSONIAN DISORDERS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS;

EID: 67649352514     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2091     Document Type: Article

References (21)

1. Caligiuri MP, Rockwell E, Jeste DV. 1998. Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication. Am J Geriatr Psychiatry 6(1): 75-82.
2. Caligiuri MP, Lacro JP, Jeste DV. 1999. Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics. J Clin Psychopharmacol 19(4): 322-328.
3. Cohen J. 1968. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psycho Bull 70: 213-220.
4. Conger AJ. 1980. Integration and generalization of kappas for multiple raters. Psychologic Bull 88(2): 322-328.
5. Cronbach LG. 1951. Coefficient alpha and the internal structure of test. Psychometrica 16: 197-334.
6. Dean CE, Russell JM, Kuskowski MA, et al. 2004. Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements? J Clin Psychopharmacol 24(3): 298-304.
7. Hawley CJ, Fineberg N, Roberts AG, et al. 2003. The use of the Simpson Angus Scale for the assessment of movement disorder: a training guide. Int J Psychiatry Clin Pract 7(4): 249-257.
8. Honer WG, Kopala LC, Rabinowitz J. 2005. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness. J Psychopharmacol 19(3): 277-285.
9. Janno S, Holi MM, Tuisku K, Wahlbeck K. 2005. Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population. BMC Neurol 5(1): 5.
10. Landis JR, Koch GG. 1977. The measurement of observer agreement for categorical data. Biometrics 33(1): 159-174.
11. Lejoyeux M, Gorwood P, Stalla-Bourdillon A, Ades J. 1993. Translation and application of the Simpson and Angus Scale of Extrapyramidal Symptoms. Encephale 19(1): 17-21.
12. Loonen AJ, Doorschot CH, van Hemert DA, et al. 2000. The Schedule for the Assessment of Drug-Induced Movement Disorders (SADIMoD): test-retest reliability and concurrent validity. Int J Neuropsychopharmacol 3(4): 285-296.
13. Loonen AJ, Doorschot CH, van Hemert DA, et al. 2001. The schedule for the assessment of drug-induced movement disorders (SADIMoD): inter-rater reliability and construct validity. Int J Neuropsychopharmacol 4(4): 347-360.
14. Loonen AJ, van Praag HM. 2007. Measuring movement disorders in antipsychotic drug trials: the need to define a new standard. J Clin Psychopharmacol 27(5): 423-430.
15. Nunnally JC Jr. 1970. Introduction to Psychological Measurements. McGraw-Hill: New York.
16. Quinn N. 1995. Parkinsonism - recognition and differential diagnosis. BMJ 310(6977): 447-452.
17. Shrout PE FJ. 1979. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86: 420-428.
18. Simpson GM, Angus JW. 1970. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212: 11-19.
19. Streiner DL, Norman GR. 1995. Health Measuring Scales: A Practiacal Guide to Their Development and Use, 2nd edn. Oxford University Press: New York.
20. Sweet RA, DeSensi EG, Zubenko GS. 1993. Reliability and applicability of movement disorder rating scales in the elderly. J Neuropsychiatry Clin Neurosci 5(1): 56-60.
21. Weiden PJ, Mann JJ, Haas G, et al. 1987. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. Am J Psychiatry 144(9): 1148-1153.